BioSpace News Archive

Transparency Market Research has published a new report titled, ‘Durable medical equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global foley catheters market is projected to register steady growth over the forecast period from 2021 to 2031, as per a research study by Fact.MR.

EsoCap AG, the Swiss biotech company dedicated to improving the lives of patients with serious diseases of the upper gastrointestinal tract, owns and develops the worldwide first local Esophagus therapy.

ITM AG, a leading radiopharmaceutical company, announced that it will host a virtual industry satellite symposium titled, “A Global Perspective on the Management of Neuroendocrine Tumors – the Evolving Role of Targeted Radionuclide Diagnostics and Therapy” at the European Society of Medical Oncology Congress 2021.

LEXEO Therapeutics announced that it closed a $100 million Series B financing, led by D1 Capital Partners and Eventide Asset Management.

Fennec Pharmaceuticals Inc. announced that management will participate in three upcoming virtual investor conferences, including H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place September 20-23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference taking place September 27-30, 2021.

Berkeley Lights, Inc., a leader in digital cell biology, announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021.

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, provides updates on recent and upcoming developments.

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced a paper, titled “A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2,” is available on medRxiv.